Feng et al. found YB-1/Smad7 could interfere with anti-proliferative/tumor-suppressive TGF-β actions in a subgroup of HCC cells, which may facilitate aspects of tumor progression [17]. The gene discussed is SMAD7; the disease is hepatocellular carcinoma.